Rigel Reports First Quarter 2024 Financial Results and Provides Business Update
Go back to Rigel Reports First Quarter 2024 Financial Results and Provides Business Update| Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) | Delayed: 45.10 -1.86 (3.96%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $46.96 | 52 Week High | $4.38 | |||
| Open | $46.24 | 52 Week Low | $1.88 | |||
| Day High | $47.34 | P/E | N/A | |||
| Day Low | $44.80 | EPS | $-1.12 | |||
| Volume | 122,514 | |||||

